ArticleOpen forum infectious diseases2026
Implementation of a Hepatitis C Screening Program for At-Risk Former Soviet-Bloc Immigrants in a Large Health Maintenance Organization.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatitis C virus (HCV) is a leading cause of liver disease worldwide. In 2021, Israel's Ministry of Health launched a national program to screen high-risk populations, especially immigrants from former Soviet Union countries, aiming to reduce HCV-related morbidity and mortality. This study evaluates the success of Maccabi Health Services (MHS) in implementing the screening program before and after the intervention, focusing on detection, treatment, and cure rates. Methods: A retrospective interrupted time-series cohort study was conducted among MHS members born in former Soviet Union countries, between 2019 and 2024. The intervention included proactive referrals for HCV antibody testing, educational messaging, and removal of bureaucratic barriers. Key outcomes were number of tests performed, positivity rates, polymerase chain reaction (PCR) confirmation, initiation of direct-acting antiviral treatment, and sustained virologic response (SVR). Results: Of 179 658 eligible members, 82.3% were screened after the intervention (compared to only 14.2% before). The rate of positive antibody tests dropped from 2.6% preintervention to 1%-1.1% postintervention. Ninety-three percent of antibody-positive individuals underwent PCR confirmation, with 52% testing positive. Eighty-four percent of PCR-positive patients started treatment, with higher initiation rates in the early intervention group. Sixty-nine percent of treated patients underwent SVR testing after treatment, with a median time of 106 days from treatment completion. Conclusions: The proactive intervention by MHS led to a significant increase in screening coverage, detection, and treatment among the at-risk population. Removing barriers, providing education, and regular reminders were key to the program's success. This structured approach can serve as a model for screening programs in other populations and countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.